KR102999060B1 - 초고정밀 바이러스 벡터 검정 - Google Patents
초고정밀 바이러스 벡터 검정Info
- Publication number
- KR102999060B1 KR102999060B1 KR1020217038299A KR20217038299A KR102999060B1 KR 102999060 B1 KR102999060 B1 KR 102999060B1 KR 1020217038299 A KR1020217038299 A KR 1020217038299A KR 20217038299 A KR20217038299 A KR 20217038299A KR 102999060 B1 KR102999060 B1 KR 102999060B1
- Authority
- KR
- South Korea
- Prior art keywords
- cells
- virus
- gene therapy
- sample
- normal human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0091—Purification or manufacturing processes for gene therapy compositions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/426,124 | 2019-05-30 | ||
| US16/426,124 US12152281B2 (en) | 2019-05-30 | 2019-05-30 | Gene therapy vector contamination assay |
| PCT/US2020/034146 WO2020242913A1 (en) | 2019-05-30 | 2020-05-22 | Ultra-high-precision viral vector assay |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20220016071A KR20220016071A (ko) | 2022-02-08 |
| KR102999060B1 true KR102999060B1 (ko) | 2026-07-31 |
Family
ID=67984844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020217038299A Active KR102999060B1 (ko) | 2019-05-30 | 2020-05-22 | 초고정밀 바이러스 벡터 검정 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12152281B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3976803A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7755490B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102999060B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113874514B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020283526B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021024020A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3140145A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL288404B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020242913A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12152281B2 (en) | 2019-05-30 | 2024-11-26 | Trizell Ltd. | Gene therapy vector contamination assay |
| CN111041131B (zh) * | 2020-03-16 | 2020-07-10 | 广东永诺医疗科技有限公司 | 基于微滴式数字pcr的eb病毒检测试剂盒 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001044280A2 (en) * | 1999-12-14 | 2001-06-21 | Genovo, Inc. | Methods and compositions for the manufacture of replication incompetent adenovirus |
| US20080193484A1 (en) * | 2004-10-25 | 2008-08-14 | Biogen Idec Ma Inc. | Novel Methods for Producing Adenoviral Vector Preparations with Reduced Replication-Competent Adenovirus Contamination and Novel Adenoviral Vectors and Preparations |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410010B1 (en) * | 1992-10-13 | 2002-06-25 | Board Of Regents, The University Of Texas System | Recombinant P53 adenovirus compositions |
| US6020191A (en) | 1997-04-14 | 2000-02-01 | Genzyme Corporation | Adenoviral vectors capable of facilitating increased persistence of transgene expression |
| EP1513956A2 (en) | 2002-06-07 | 2005-03-16 | Novartis AG | Assay to detect replication competent viruses |
| WO2008079354A2 (en) | 2006-12-22 | 2008-07-03 | Schering Corporation | Methods of detecting replication competent adenovirus |
| EP2553105B1 (en) | 2010-04-01 | 2014-12-17 | Weidong Xiao | Compositions and methods for the production of recombinant virus vectors |
| CA2823193C (en) * | 2010-12-27 | 2017-06-06 | Ibis Biosciences, Inc. | Quantitating high titer samples by digital pcr |
| CN102134613B (zh) * | 2010-12-31 | 2013-01-30 | 中国人民解放军第三军医大学 | 重组慢病毒滴度的检测方法 |
| DE102012100824A1 (de) * | 2012-02-01 | 2013-09-05 | Albert-Ludwigs-Universität Freiburg | Gemultiplexte Digital PCR |
| WO2013163545A1 (en) * | 2012-04-26 | 2013-10-31 | Sentient Lifesciences, Inc. | Use of n-acetylcysteine amide in the treatment of disease and injury |
| EP3052644B1 (en) | 2013-10-01 | 2019-07-10 | Texcell | Detection of rare microbiological nucleic acids |
| WO2015103367A1 (en) * | 2013-12-31 | 2015-07-09 | Raindance Technologies, Inc. | System and method for detection of rna species |
| EP3387138B2 (en) | 2015-12-11 | 2026-05-27 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav9 |
| RS67367B1 (sr) * | 2016-04-14 | 2025-11-28 | Ferring Ventures Ltd | Bioreaktor sa fiksiranim slojem sa pumpom/sistemom creva sa konstantnim protokom |
| GB2549799A (en) * | 2016-04-29 | 2017-11-01 | Nat Univ Ireland Galway | A multiplex assay for the sensitive and specific detection and differentiation of Clostridium difficile |
| JP7483373B2 (ja) * | 2016-07-29 | 2024-05-15 | ジュノー セラピューティクス インコーポレイテッド | 複製可能ウイルスの存在または非存在を評価するための方法 |
| CN107794291A (zh) * | 2017-04-10 | 2018-03-13 | 中山大学 | 一种抗新加坡石斑鱼虹彩病毒的药物筛选方法 |
| CN108570449A (zh) * | 2018-05-17 | 2018-09-25 | 石河子大学 | 一种带有自发性kshv裂解复制的神经元细胞的构建方法 |
| US12152281B2 (en) | 2019-05-30 | 2024-11-26 | Trizell Ltd. | Gene therapy vector contamination assay |
-
2019
- 2019-05-30 US US16/426,124 patent/US12152281B2/en active Active
-
2020
- 2020-05-22 KR KR1020217038299A patent/KR102999060B1/ko active Active
- 2020-05-22 WO PCT/US2020/034146 patent/WO2020242913A1/en not_active Ceased
- 2020-05-22 AU AU2020283526A patent/AU2020283526B2/en active Active
- 2020-05-22 EP EP20812945.2A patent/EP3976803A4/en active Pending
- 2020-05-22 CN CN202080038925.9A patent/CN113874514B/zh active Active
- 2020-05-22 CA CA3140145A patent/CA3140145A1/en active Pending
- 2020-05-22 BR BR112021024020A patent/BR112021024020A2/pt unknown
- 2020-05-22 IL IL288404A patent/IL288404B2/en unknown
- 2020-05-22 JP JP2021569884A patent/JP7755490B2/ja active Active
-
2024
- 2024-11-07 US US18/940,233 patent/US20250163519A1/en active Pending
-
2025
- 2025-06-13 JP JP2025099242A patent/JP2025123368A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001044280A2 (en) * | 1999-12-14 | 2001-06-21 | Genovo, Inc. | Methods and compositions for the manufacture of replication incompetent adenovirus |
| US20080193484A1 (en) * | 2004-10-25 | 2008-08-14 | Biogen Idec Ma Inc. | Novel Methods for Producing Adenoviral Vector Preparations with Reduced Replication-Competent Adenovirus Contamination and Novel Adenoviral Vectors and Preparations |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020242913A1 (en) | 2020-12-03 |
| EP3976803A1 (en) | 2022-04-06 |
| CA3140145A1 (en) | 2020-12-03 |
| US20190292609A1 (en) | 2019-09-26 |
| IL288404B2 (en) | 2025-03-01 |
| JP2022534483A (ja) | 2022-08-01 |
| US20250163519A1 (en) | 2025-05-22 |
| IL288404B1 (en) | 2024-11-01 |
| US12152281B2 (en) | 2024-11-26 |
| KR20220016071A (ko) | 2022-02-08 |
| CN113874514A (zh) | 2021-12-31 |
| AU2020283526A1 (en) | 2021-12-23 |
| AU2020283526B2 (en) | 2026-07-16 |
| IL288404A (en) | 2022-01-01 |
| JP7755490B2 (ja) | 2025-10-16 |
| JP2025123368A (ja) | 2025-08-22 |
| EP3976803A4 (en) | 2023-11-22 |
| CN113874514B (zh) | 2026-07-10 |
| BR112021024020A2 (pt) | 2022-04-12 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| D13-X000 | Search requested |
St.27 status event code: A-1-2-D10-D13-srh-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11 | Administrative time limit extension requested |
Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11 | Administrative time limit extension requested |
Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| F11 | Ip right granted following substantive examination |
Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| U12 | Designation fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| Q13 | Ip right document published |
Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE) |